Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	255.5	264.55	270.5	157.64	137.98	158.03
Cash & Short-Term Investments	255.5	264.55	270.5	157.64	137.98	158.03
Cash Growth	15.53%	-2.20%	71.60%	14.25%	-12.69%	30.96%
Accounts Receivable	238.83	184.33	135.04	131.31	122.42	112.99
Other Receivables	17.53	23.59	26.38	10.84	10.31	22.18
Receivables	256.36	207.92	161.42	142.15	132.72	135.17
Inventory	257.15	248.55	243.07	235.18	222.19	151.27
Prepaid Expenses	-	5.39	2.08	6.52	1.9	0.67
Other Current Assets	-	-	-	-	-	14.56
Total Current Assets	769.01	726.4	677.07	541.49	494.8	459.69
Property, Plant & Equipment	567.51	567.52	582.37	579.92	542.53	441.79
Long-Term Investments	22.59	22.67	36.91	42.15	73.54	112.25
Other Intangible Assets	43.07	7.32	7.65	3.84	4.95	4.66
Long-Term Deferred Tax Assets	14.82	15.33	8.95	13.33	12.7	8.54
Long-Term Deferred Charges	-	37.55	31.15	40.14	34.58	30.41
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.05	1.1
Total Assets	1,418	1,378	1,345	1,222	1,164	1,058
Accounts Payable	153.71	55.89	40.45	51.93	31.32	28.15
Accrued Expenses	-	46.92	33.79	40.46	61.2	45.62
Short-Term Debt	-	32.33	50.59	101.8	87.85	36.11
Current Portion of Long-Term Debt	37.03	15.66	14.95	32.34	15.08	12.68
Current Portion of Leases	-	0.55	0.92	0.94	0.64	0.6
Current Income Taxes Payable	2.37	0.74	0.37	1.17	6.06	0.74
Other Current Liabilities	-	25.89	25.65	35.95	28.17	26.41
Total Current Liabilities	193.1	177.99	166.73	264.59	230.31	150.32
Long-Term Debt	455.11	464.52	480.9	294.6	297.8	253.28
Long-Term Leases	2.99	2.76	1.48	1.92	2.48	0.66
Long-Term Deferred Tax Liabilities	30.74	23.42	8.91	5.58	9.54	10.35
Total Liabilities	681.95	668.68	658.01	566.7	540.13	414.61
Common Stock	432.47	432.47	432.47	419.37	405.86	404.92
Retained Earnings	381.38	354.78	319.07	288.37	239.97	220.18
Comprehensive Income & Other	-77.76	-78.09	-64.41	-52.52	-21.82	18.72
Shareholders' Equity	736.09	709.15	687.12	655.22	624	643.82
Total Liabilities & Equity	1,418	1,378	1,345	1,222	1,164	1,058
Total Debt	495.12	515.82	548.85	431.6	403.84	303.33
Net Cash (Debt)	-239.62	-251.28	-278.35	-273.97	-265.86	-145.31
Net Cash Per Share	-0.25	-0.26	-0.29	-0.29	-0.29	-0.16
Filing Date Shares Outstanding	961.94	961.94	961.94	952.24	941.77	941.37
Total Common Shares Outstanding	961.94	961.94	961.94	952.24	941.77	941.37
Working Capital	575.91	548.42	510.34	276.9	264.49	309.37
Book Value Per Share	0.77	0.74	0.71	0.69	0.66	0.68
Tangible Book Value	693.02	701.84	679.47	651.38	619.06	639.16
Tangible Book Value Per Share	0.72	0.73	0.71	0.68	0.66	0.68
Land	-	65.68	65.68	69.88	69.88	69.88
Buildings	-	267.09	265.86	125.23	124.51	119.57
Machinery	-	452.39	435.18	368.47	308.94	291.64
Construction In Progress	-	12.19	8.48	172.65	162.63	65.81

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.